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The effects caused to articular cartilage by the remote use of arthroscopicallydelivered RF energy to soft tissues in the joint are unknown. This investigation reported
the short and long-term effects of bRF and mRF energy on the biomechanical properties
and metabolic activity of articular cartilage. In addition, the effect of Cosequin® therapy
was addressed. Thirty New Zealand white rabbits were randomly assigned to one of two
treatment groups (Group 1 - placebo; Group 2 - Cosequin®).

Histopathology, cell

viability, GAG synthesis, and mechanical function of the articular cartilage were
compared between groups. Data were analyzed using a mixed model ANOVA (p=0.05).
Immediate chondrocyte death was created by both RF devices. This damage was noted
to be superficial and did not lead to the progressive deterioration of the extracellular
matrix or mechanical function of the articular cartilage. Cosequin® therapy was unable
to demonstrate significant differences compared to the control group.
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CHAPTER I
INTRODUCTION
Heat has been used in surgery since first described in the fourth century BC by
Hippocrates. Since that time dramatic advances have been made that allow greater
control in applying heat to both cauterize and cut body tissues.

The evolution of

electrosurgery has moved from the use of laser energy to radiofrequency (RF) energy.
Clinical and scientific reviews of the use of radiofrequency energy in arthroscopy began
to appear in the literature in the late 1990’s. Since then many researchers and clinicians
have evaluated the basic science and clinical outcomes associated with the use of RF on
human and animal joint structures. This article will review the use of RF energy during
arthroscopic surgery; addressing the basic science, the types of radiofrequency energy
available, and the effects of RF energy on supportive structures (e.g., joint capsule,
ligaments, etc.) and articular cartilage within the joint.
BASIC SCIENCE
Electrocautery refers to a modality in which the tip of an instrument is heated with
an electric current. This causes the affected tissues to be heated from the outside inward
via thermal conduction. Electrocautery is inexact in its application and can lead to
widespread tissue damage. Electrosurgery, on the other hand, refers to the passage of a
current through the tissue, causing it to heat from the inside out. The tip of the device
1
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does not increase in temperature (except by heat transfer from the tissue). Electrosurgery
provides a more controlled treatment with less collateral tissue damage.
Electrical current can either be direct (flows in one direction) or alternating.
When applied to living tissues, direct current will depolarize some of the cell membranes
resulting in muscle and nerve excitation. When current duration exceeds the capacity of
the cell to repolarize, the cell enters a refractory period and activity ceases. If this
persists long enough, cell death can occur. However, cell viability can be maintained if
the intermittent current pulses are applied in a manner that allows for the interval
repolarization of some of the cellular membranes.1 D’Arsonval published an experiment
in the late 1800’s in which he passed alternating current through the human body.2 He
found that current with a frequency less than 10,000 Hz (1Hz = 1 cycle per sec) caused
undesirable neuromuscular stimulation. However, when the frequency was increased to
more than 10,000 Hz muscular contractions were no longer present. The power company
sends out an alternating current of 110 volts with a frequency of 60 Hz. To convert this
current to a desired voltage and frequency, a step-up transformer increases the voltage
and a steady-state oscillating circuit increases the frequency to over 10,000 Hz.
Amplitude modulation (AM) radiowaves fall into the 55,000-160,000 Hz range of the
electromagnetic spectrum. This is the same frequency at which electrosurgical current is
used and, thus, electrosurgery is often referred to as radiosurgery.
Electrosurgical or radiosurgical currents can be altered into different waveforms
that will perform a variety of functions. Coagulation is accomplished with a “damped”
wave. The damped current starts at a given voltage and gradually decreases in amplitude
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until it returns to zero. This leads to a brief moment where there is actually no current.
This on/off cycle is referred to as intermittent current.

Cutting is achieved with a

“rectified” wave. This is also an intermittent current, but the amplitude does not decrease
as in the “damped” wave. Filtering can be used to convert an intermittent current into a
constant one. Pollack described four factors that influence the degree to which tissues are
damaged during radiosurgery: the surface area of the treatment electrode, the time that
the electrode is in contact with the tissue, the power setting, and the type of current (e.g.,
damped, rectified).3 Taking all of these factors into consideration, the most precise cut
with the minimum amount of peripheral tissue damage will result from the optimum
combination of limited contact time, power setting, treatment electrode surface area, and
a fully rectified and filtered current. Thermal energy for radiosurgery can be delivered
arthroscopically by use of laser or RF energy probes.
Laser vs. RF Energy
Three laser systems have been used in arthroscopic surgery: carbon dioxide
(CO2),

neodymium:yttrium-aluminum-garnet

(Nd:YAG),

and

holmium:yttrium-

aluminum-garnet (Ho:YAG) laser systems.4 The CO2 laser was first used in the early
1980s and required gaseous insufflation of the joint with CO2. It lost its popularity
because of the cumbersome delivery system, the potential for subcutaneous emphysema,
and its propensity to cause CO2 laser-induced synovitis. The use of Nd:YAG laser
energy is limited as it creates considerable collateral tissue damage and fracturing of the
probe tip permits uncontrolled escape of damaging laser energy. In 1987, the Ho:YAG
laser was introduced as the first fiberoptic-delivered laser beam for arthroscopic
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application in a water medium. However, the start-up cost of a Ho:YAG laser system
exceeds $100,000. Its use has become limited since it is more expensive to use than
traditional instrumentation and it has not been found to significantly improve
postoperative performance in human clinical trials.
The use of RF energy with arthroscopy was first described in the late 1990’s.
Unlike laser systems which use direct photostimulation of cellular ions to produce heat,
RF devices pass a high-frequency, alternating current from an electrical generator to the
probe tip and into the tissue, leading to ionic agitation and eventual frictional heating
within the tissue. This heat may be lost from the tissue by heat diffusion (conduction),
lost in the irrigating solution (convection), or diverted into the circulating blood. In
addition, the heat generated by the RF probe exponentially decreases as the distance (r)
from the electrode tip increases, by a factor of 1/r4.5 Heat generated within the tissue is
also directly influenced by the RF current intensity (I), by a factor of I2, and the time (T)
that the RF energy is delivered to the tissue. Therefore the heat generated varies as I2T.5
Radiofrequency energy can either pass from the probe tip to a grounding pad
(monopolar) or it can pass between two points within the same probe tip (bipolar).
Types of RF Used Arthroscopically
Monopolar: The Vulcan EAS generator (Oratec Interventions Inc, Menlo Park,
California) is the only monopolar RF (mRF) unit available for arthroscopic usage. The
current generated by this unit passes through the connection cable, through the probe
(active electrode), through the patient to a return electrode (indifferent electrode or
ground pad), and then back to a return in the RF unit. When RF energy is applied at
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greater than 300 kHz, intracellular and extracellular ions have insufficient time to
physically move from one side of the cell to the other.6 This causes molecular friction.
Heat is produced within the tissues as a result of this friction (resistive heating) because
the tissue has a greater resistance than other parts of the circuit. This differs from laser
energy, which produces heat through direct photostimulation of cellular ions. Thus,
molecular friction is the source of the heat generated with RF energy and not the probe
tip itself.7
The mRF device also has the added benefit of having probes with thermometric
tips that can measure the temperature generated by the unit. The temperature is measured
50 times per second, and the voltage of the system is automatically adjusted to maintain
the set temperature. In addition, both the temperature and the wattage can be adjusted to
the ideal setting for the situation. As with all RF devices, there are a variety of different
probe shapes, sizes, and functions for the necessary treatment.
Bipolar:

There are two bipolar RF (bRF) devices available for use in

arthroscopic surgery, ArthroCare 2000 (ArthroCare Corp, Sunnyvale, California) and
Mitek VAPR (Mitek Products, Westwood, Massachusetts). Bipolar RF units produce
heat within tissues similar to mRF devices. However, bRF devices place both electrodes
(active and ground) within the probe tip and do not require RF energy to course through
the patient to create thermal changes. In addition, the manufacturers of ArthroCare claim
that their system may also be used for ablative procedures using a process they call
coblation (“cold ablation”). Coblation replaces the thermally damaging vaporization and
pyrolysis of standard electrosurgery with molecular disintegration via a cold ablative
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process most closely resembling that of exclimer lasers. This is achieved by employing
8

an electrically conductive fluid (e.g., isotonic saline) in the physical gap between the
electrode and tissue.

Once a sufficiently high voltage difference has been created

between the electrode and the tissue, the electrically active conducting fluid is converted
into an ionized vapor layer, or plasma. As a result of the voltage gradient across the
plasma layer, charged particles are accelerated towards the tissue. At sufficiently high
voltage gradients, these particles gain adequate energy to cause dissociation of the
molecular bonds within tissue structures.8

This molecular dissociation produces

volumetric removal of tissue. However, due to the short range of the accelerated particles
within the plasma, this dissociative process is confined to the surface layer of the target
tissue. In this way, coblation enables volumetric removal of the target tissue without
producing extensive collateral damage.
The power setting on the bRF device can be adjusted as with the mRF device;
however, the temperature and wattage cannot be independently set by the operator. The
bRF device also does not contain a thermometric probe tip, and thus the voltage used is
constant. As with the mRF system, there are a variety of sizes and shapes of RF probes
available for arthroscopic use.
EFFECTS OF RF ON THE JOINT CAPSULE
Instability of the human glenohumeral joint is a challenging problem facing
orthopedic surgeons worldwide. Shoulder instability is a growing concern in many
veterinary patients with fore limb pain localized to the glenohumeral joint. Traditionally,
this condition has been treated with medical management or arthrotomy with surgical
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stabilization. In the mid-90s, Thabit presented a multi-institutional study involving the
treatment of human unidirectional and multidirectional glenohumeral instability with
arthroscopically delivered laser energy.9 This treatment was shown to visibly shrink the
joint capsular tissue, and the patients were clinically improved over the six months of the
evaluation. Following this investigation, researchers began to investigate the mechanical,
biochemical, and biologic changes associated with laser and RF energy use on joint
capsular tissue.
Joint Capsular Shrinkage
The magnitude of joint capsular shrinkage caused by RF energy application has
been extensively evaluated in cadaveric specimens. It was discovered that increasing
power (watts)10-13 or temperature11,14-17 led to a significant increase in tissue shrinkage.
The tissue shrinkage was immediate, and its magnitude correlated directly with the
increases in power or temperature.
RF energy has been shown to cause significant tissue shrinkage when the
temperature setting of the unit is greater than 65ºC. Although significantly greater tissue
shrinkage is noted when the temperature increases, it appears that there is a maximum
amount of tissue shrinkage that can be achieved by the application of RF energy. No
added benefit was noted when temperatures greater than 75ºC were used to shrink joint
capsular tissue.11,16,17 Histologically, significantly greater tissue damage was seen when
temperatures greater than 75ºC were compared to 65ºC. 11,16,17
In addition to controlling the temperature of RF energy, the power or wattage can
also be regulated with mRF. It was noted that a significant increase in tissue lesion area
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and lesion depth in joint capsular tissue was created when the power of the RF energy
used was increased.10 When mRF energy was applied at 65ºC and 10 W of power, the
depth of tissue penetration was 0.95 ± 1.16 mm. However, when mRF energy was
applied at 65ºC and 30 W of power, the depth of tissue penetration increased to 4.75 ±
1.25 mm.
In 2000, Lu et al. evaluated the effect of different treatment delivery patterns on
tissue shrinkage.18 It was noted that when joint capsular tissue was treated with mRF
energy at a temperature of 70ºC and a power setting of 15 W there was no significant
difference in the amount of tissue shrinkage when a grid-like treatment pattern was
compared to a paintbrush-like pattern (27% ± 8.7% and 29% ± 7.9%, respectively). The
grid-like treatment pattern consisted of multiple, single, linear passes over the treatment
area while the paintbrush-like pattern consisted of diffuse treatment of the entire area.
When Osmond et al. compared laser energy to mRF energy, it was noted that the
mean shrinkage of joint capsular tissue was not significantly different between 10 and 15
W of laser energy and 75ºC of RF energy (42%, 41%, and 45% respectively).11 It was
also noted that laser energy applied at 5 W and RF energy applied at 55ºC were not
significantly different than controls.
Joint capsular tissues were also placed in fluid baths at different temperatures for
different lengths of time to assess the effect that temperature had on tissue shrinkage,
independent of laser or RF energy. The effects of temperature alone on joint capsular
tissue have also been analyzed. Tissues treated at or above 65ºC resulted in significant
tissue shrinkage, with no differences noted between tissues placed in the 75º and 85ºC

fluid baths.

15,20
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Naseef et al. did find significant shrinkage of joint capsular tissue at

60ºC; however, this effect was not noted until the tissue had been in the water bath for
over 5 minutes.15 All effects at or above 65ºC were noted to be immediate. 15,20
It appears that the effects of laser and RF energy on joint capsular shrinkage are
thermally induced. These effects are temperature and power sensitive. In addition, there
is a maximum limit to the amount of tissue shrinkage achievable. This maximum amount
of tissue shrinkage can be obtained by either a grid or paintbrush treatment pattern. In
addition, to increase the depth of tissue penetration created by RF energy one can
maintain a constant temperature setting while increasing the power (wattage) of the RF
delivery system.
Treatment Temperatures
Obrzut et al. noted that the recorded tissue temperatures, 0.3-mm below the probe,
were 3.7º to 6.7ºC below the set temperatures of the RF device.16 Many authors have
noted that tissue temperature decreases as the distance from the probe tip
increases.5,11,12,16 Obrzut et al. also found that when RF energy was applied as high as
80ºC, the maximum temperature in joint capsular tissue 1.5-mm from the probe never
exceeded 45ºC.16 Osmond et al. found mean tissue temperatures 0.3-0.5 mm below the
probe to be between 55º and 65ºC when RF energy was applied at 65º-75ºC.11 Tissue
temperatures 4.5 mm from the probe were not significantly different than controls when
RF energy was applied.16
Shellock et al. noted that when the power setting of the bRF unit (Mitek) was
increased, a subsequent increase in tissue temperature was found with 10, 16, and 20 W

of power leading to 50.0º-66.0º, 62.9º-70.7º, and 71.2º-76.8ºC, respectively.

12
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The higher

temperatures noted at each power setting were created by probes that had larger surface
areas at the tip. The authors concluded that the surface area of the probe tip had a
significant effect on tissue temperature, and larger probe tips generated higher tissue
temperatures.
Recently, Lu et al. applied RF energy to joint capsular tissue in an artificial joint
and recorded the fluid temperatures generated.19 One mRF device (Oratec) and two bRF
devices (ArthroCare and Mitek) were assessed in this investigation. All devices were
used to deliver RF energy in both an intermittent and continuous fashion, with and
without fluid flow. It was found that all fluid temperatures generated were below 40ºC
when tissue was treated either intermittently (on for 10 seconds and off for 5 seconds for
5 treatments) or continuously (on for 3 minutes) under continuous fluid flow of
200ml/min.

For intermittent treatment without flow, both bRF devices created

significantly greater fluid temperatures than the mRF device. The ArthroCare (bRF)
device was noted to create the highest tissue temperatures (46ºC at 55 seconds and 52ºC
at 70 seconds). When continuous treatment was evaluated without flow, it was again
noted, that bRF energy created greater fluid temperatures than mRF energy.

The

ArthroCare (bRF) device led to temperatures around 65ºC at 2 minutes and 80ºC at 3
minutes while the Mitek (bRF) device created temperatures around 52ºC at 3 minutes. In
addition, fluid temperatures were still in excess of 75ºC 30 seconds after the ArthroCare
(bRF) device was turned off. Overall, when RF energy was applied intermittently it led
to lower temperatures than when applied continuously.
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Tissue temperatures appear to be greatly affected by the amount of power used
and the distance the tissue is located from the probe tip. An increase in power will
generate higher tissue temperatures and as the distance from the probe tip increases the
tissue temperature will decrease. In addition, when RF settings are equal (temperature,
power, etc.), a greater surface area at the end of the probe tip will generate greater tissue
temperatures. Finally, fluid temperatures can be affected by the manner in which RF
energy is applied (continuous vs. intermittent) and whether or not there is continuous
flow of fluids during RF energy application. It appears that intermittent treatment under
continuous flow will generate the lowest joint fluid temperatures.
Microscopic Evaluation of Treated Tissues
As was stated previously, all effects created by RF energy in the joint capsule are
visible instantaneously. These effects include significant tissue shrinkage that leads to a
thickening of the joint capsular tissue. These changes are grossly evident for 30 to 60
days after RF application. After 60 days, however, the treated tissues grossly appear very
similar to the control tissues.
Regardless of whether the joint capsule is treated with laser energy, RF energy, or
the tissue is merely placed in a heated fluid bath, the resultant histological effects are
similar. The following microscopic changes are evident with as little as 5 W of laser
energy, 45ºC of RF energy, or 65ºC of heated fluid.

The primary changes noted

histologically include diffuse hyalinization and fusion of the collagen fibrils immediately
after thermal treatment.14,15,18,20-24

In addition, necrosis of fibroblasts is evident by

pyknosis, karyorrhexis, and fragmentation of the nucleus.

14,15,18,20-24

Lopez et al. also
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noted that as the temperature of RF energy increased the amount of collagen fusion and
the percent area affected also increased (22.5% for 45ºC and 50.4% for 85ºC).23 When
transmission electron microscopy (TEM) was used to evaluate the ultrastructural changes
immediately following joint capsular treatment, it was noted that the treated collagen
began to increase in cross-section area, and the margins began to lose their distinct edges
while maintaining a circular shape.14,20,22,24-27

These fibrils also became more

homogenous in size than those of the control tissues that had a variety of collagen fibril
diameters. Additionally, the cross-sectional area of the collagen fibrils increased as the
power/wattage of the energy device was elevated.22,25 TEM also revealed that the treated
tissue had a generalized decrease in cellularity, and the remaining intact fibroblasts
contained pyknotic nuclei immediately after thermal treatment.20,22,24,26 When CLM and
a live/dead cell staining technique were used to evaluate RF treated tissues immediately
after RF application, a clear demarcation was noted. No live cells were evident within
the treated tissue, and the surrounding tissue was filled with live fibroblasts.18
Although many of the initial histological investigations involved cadaveric
samples, the biological response following the application of laser or RF energy in the
treated tissue was of great interest. Many studies noted that within the first week or two
after thermal treatment an active capillary and fibroblastic response surrounded a distinct
area of acellularity when the tissues were examined with light microscopy.10,18,20,24,26
TEM revealed similar findings; however, the fibroblasts bordering the acellular region
were large, filled with well developed endoplasmic reticulum (ER), and surrounded by
finely secreted collagen fibrils.20,24,26 When CLM was used for evaluation, Lu et al.
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found only a few viable cells within the treated region during the first couple of weeks
following RF application.18
Within one month after treatment, the inflammatory cells and active fibroblasts
surrounding the treated tissue began to invade the acellular region and deposit
collagen.18,24,26,28 Ultrastructurally, TEM revealed increased cellularity within the treated
tissues, and the cytoplasm of these fibroblasts contained more secretory vesicles than
normal with a greater arrangement of rough ER, golgi apparatus, and mitochondria.20,22,26
At six weeks following RF application, TEM revealed that the acellular region was
completely incorporated with fibroblasts, and the large, swollen collagen fibrils were
replaced by a homogenous array of small collagen fibrils.24
At two months following thermal treatment, histopathology revealed that the
treated area had normal vascularity; however, the cellularity continued to be
increased.26,29 TEM revealed that the entire acellular region was covered with normal
appearing collagen by 60 days after treatment.26 When Lu et al. compared the biological
response of joint capsular tissue treated with multiple linear passes (grid-like) to the
diffuse treatment of a specific area (paintbrush-like), the grid-like treatment was entirely
incorporated with viable cells (CLM) while the paintbrush-like treatment still had
avascular areas six weeks following treatment.18
At three months after treatment, hyalinized collagen and necrotic cells were no
longer evident histologically; however, the treated region still had increased
cellularity.18,21,24,26 Ultrastructurally, the collagen fibrils appeared normal, but there was
still an increase in the number of active fibroblasts when compared to normal tissue.24
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CLM revealed viable cells incorporating the entire treatment region by three months
regardless if the tissue was treated in a grid-like or paintbrush-like manner.18
When tissues were evaluated at 6 months after thermal application, the fibroblasts
appeared less active and the vascularity appeared to have decreased when compared to
the tissues at three months.24 There were, however, still a greater number of fibroblasts
in the treated tissue than normal.21,26

Fibroblasts and collagen also had a normal

appearance when viewed with TEM at six months after thermal treatment, but the crosssectional area of the collagen fibrils appeared to be uniformly smaller than controls.26
It appears that thermal heating of joint capsular tissue, whether with laser energy,
RF energy, or a heated fluid bath, leads to the immediate damage of the collagen and
fibroblasts in the treated area. Initially, the collagen fibrils swell and appear to fuse while
the fibroblasts are severely damaged. Within a week, the treated tissue is surrounded by
active fibroblasts. These fibroblasts begin to invade the acellular region approximately
one month after treatment and lay down new collagen. Within 60 days the treated tissue
begins to look more normal histologically, but continues to have an increase in cellularity
as long as 6 months after treatment. Joint capsular tissue also appears to regain a more
normal appearance sooner when it is treated in a grid-like pattern when compared to a
paintbrush-like pattern.
Mechanical Changes Associated with Treated Tissues
The mechanical function of the treated joint capsular tissue became of utmost
importance as changes in the joint capsule will dictate the overall function of the joint.
When evaluating the mechanical function of the joint capsule, one must evaluate both its
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structural and material properties. The relationship of these two tissue properties is
important in determining whether the structural integrity and the intrinsic nature of the
joint capsule can recover following thermal injury.
It was noted that when joint capsular tissue was treated with RF energy the tissue
stiffness (resistance to load or stretching of the joint capsule) was initially decreased.17,24
The decrease in joint capsular stiffness remained for the first two weeks after RF
application, but returned by six weeks, and tissues evaluated at 6 and 12 weeks were not
significantly different than controls.24 When tissue was treated in a grid-like fashion, the
tissue stiffness was significantly greater than tissue treated in a diffuse (“paintbrush”)
manner at six weeks after RF application; however, no other differences were noted at 0,
2, or 12 weeks in the study.18
The reported percent relaxation (which is a measure of how much an applied load
relaxes the joint capsule with time when subjected to a constant deformation) of the joint
capsular tissue has varied in published articles. Hecht et al. reported an initial increase in
percent relaxation24 while Lopez et al. reported no difference in percent relaxation
between the control and treated tissues.17 When calculating the percent relaxation, both
studies subjected treated tissue to a similar stress-relaxation test where the tissue was
stretched to a 10% strain.17,24 Hecht et al. noted that the increase in percent relaxation of
treated tissue was significant greater than control tissue at weeks 0 and 6, but the percent
relaxation at weeks 2 and 12 was not.24 In addition, Lu et al. noted that tissue treated in a
paintbrush-like fashion had a significantly greater percent relaxation than tissue treated in
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a grid-like manner immediately after RF application; however, no significant differences
were noted at any other stage of the study.18
Tissue strength was not significantly different at any time when treated joint
capsular tissue was compared to control tissue for 12 weeks after RF application;
however, the tissue strength of treated tissue at 2 weeks after application was
significantly less than that at 12 weeks.24 In addition, Lu et al. noted that there was
significantly less tissue strength at 0 and 2 weeks after RF application in tissue treated in
a paintbrush-like pattern when compared to tissue treated in a grid-like manner; however,
there were no significant differences between the two treatment patterns at 6 and 12
weeks.18 No significant differences were noted between the treated and control tissues in
any of the measured parameters at 12 weeks following RF application.18,24
Wallace et al. created stifle joint instability by moving the insertion of the medial
collateral ligament (MCL) proximally and cranially on the tibia.27 The MCL was then
treated with RF energy to eliminate this created instability.

The investigators then

evaluated tissue creep, a time dependent increase in deformation, both cyclically (30
cycles at 5% ultimate stress of a normal MCL) and statically (following the 30 cycles the
load was held constant for 20 minutes). It was noted that, immediately after RF energy
application, the treated tissue had a cyclic creep strain that was three times that of normal
MCL tissue and a static creep strain that was two times that of normal MCL tissue. In
addition, low load stiffness was calculated from the ratio of load to deformation at the
peak of the first cycle, and the treated tissue had a low load stiffness that was 25% that of
a normal MCL.
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Overall, treated tissues appear to lose tissue stiffness and may have a greater
percent relaxation immediately after thermal treatment. Within six to 12 weeks, the
mechanical properties of the treated tissues are regained to near normal strength. Tissue
treated in a grid-like pattern regains mechanical function quicker than tissues treated in a
paintbrush fashion. These mechanical changes correlate in time with the previously
reported histological changes. These findings indicated that RF treated tissues may need
to be immobilized for 6 to 12 weeks after surgery in order for the tissue to regain normal
strength.
Biochemical Response of Treated Tissues
Hayashi et al. investigated the effects of laser treatment on collagen and the
subsequent response of the treated collagen to trypsin digestion.22

Trypsin is a

proteolytic enzyme that will denature collagen fibrils only after the normal triple helix
has been unfolded. Hayashi et al. noted that treated collagen not digested with trypsin
and control tissues digested in trypsin had distinct α-bands of Type I collagen. However,
when treated tissue was digested with trypsin there was a significant loss of these αbands.22 This indicates that laser treated collagen exposes cleavage sites for trypsin in the
collagen molecule by unwinding the triple helix structure. This test may also be an
indicator of the degree of collagen denaturation.
In a similar study, Hayashi et al. examined the molecular response of laser treated
joint capsule for up to six months after the application of laser energy.26 A significant
decrease in the α-bands of Type I collagen were noted for the first 30 days after surgery.
In addition, the trypsin susceptibility index (TSI) which was initially decreased began to

gradually return to near normal values.

26
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This is indicative of the production of new

native collagen. Hayashi et al. also noted an immediate decrease in collagen synthesis of
the laser treated tissue immediately after application. This decrease was followed by a
significant increase in collagen synthesis from days three to fourteen after treatment.
From one to six months after laser treatment no significant differences were noted in
treated and control tissue.26 Hecht et al. is the only author to report the TSI of joint
capsular tissue following RF application.24 These results were similar to those following
laser treatment where the TSI was significantly decreased for the first two weeks after RF
treatment.

However, the TSI subsequently increased until there was no significant

difference between the TSI in the treated tissues at 6 and 12 weeks and the TSI of control
tissues.
In general, it appears that changes in the joint capsule created by laser and RF
energy are related to an unwinding of the collagen molecule. New collagen begins to be
produced as early as three days after the insult. The amount of new, native collagen in
the exposed area appears to be similar to pretreatment levels as early as one month posttreatment; however, from the previous data this collagen does not reach full strength until
a later time.
EFFECTS OF RF ON ARTICULAR CARTILAGE
Many humans suffer from partial or full-thickness articular cartilage lesions that
lead to significant pain and diminished function. Traditional treatment has focused on
either treating the lesion with a mechanical shaving device or converting the partialthickness lesion to a full-thickness lesion and allowing it to fill with fibrocartilage.
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Newer treatment modalities have included the application of laser or RF energy to the
damaged cartilage surface.30-42
Investigators have compared the changes that occur in the articular cartilage
following the application of both types of RF energy (mRF vs. bRF).35-38 CLM has been
shown to be more sensitive than traditional light microscopy in assessing the acute
changes in chondrocyte function following RF application.33,35,36,40

Newer testing

modalities recently appeared in the literature assessing the molecular changes that occur
in RF treated articular cartilage.42,43 To the author’s knowledge, only one clinical trial
has been published concerning the outcome following the use of RF energy to treat
cartilage damage.41
Laser Energy
Many of the initial investigations related to the thermal treatment of articular
cartilage involved electrocautery and laser energy. Rand et al. found that increasing the
power of laser energy created an increase in the depth of the cartilage laceration; 25W =
11.4%, 82.5W = 57%.30 Trauner et al. assessed the acute and chronic response of
articular cartilage to Ho:YAG laser energy.31 No evidence of tissue destruction was
noted at exposures <50 J/cm2; however, at >80 J/cm2 there was consistent removal of
cartilaginous tissue. Additionally, there was evidence of thermal damage 450-500µm
below the articular surface and 250µm lateral to the treatment path within the articular
cartilage. A linear relationship also was noted between the amount of energy used and
the amount of tissue destruction. The chronic effects of laser application were assessed
by artificially creating partial-thickness cartilage injuries that were either treated with
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Ho:YAG laser energy or converted to a full-thickness lesion which was then treated with
abrasion arthroplasty.31 Samples were collected at 0, 2, 4, and 10 weeks after treatment.
Histopathologic analysis revealed no healing of the laser treated defects. Chondrocyte
necrosis extended greater than 900µm from the ablation craters caused by the laser
application. In addition, chondrocyte cloning (partial-thickness) and granulation tissue
(panus; full-thickness) was observed adjacent to the created lesions. These investigations
demonstrated that although fibrillated cartilage could be smoothed with laser energy the
heat produced lead to significant chondrocyte damage.
Device Settings
In 2000, Kaplan et al. investigated the acute effects caused in the articular
cartilage by increasing the power setting/voltage of bRF.34 Bipolar (ArthroCare) RF
energy was applied to fresh human articular cartilage for three seconds at three separate
power settings; 2 (133-147 volts), 4 (161-179 volts), and 6 (190-210 volts).
Histologically, no significant changes were evident in the fibrillar component of the
extracellular matrix or ground substance. In addition, the chondrocytes adjacent to each
treated area appeared viable and similar to both control and areas remote to the treatment.
The depth of cut created by the bRF probe gradually increased as the power setting
increased (0.12 mm – setting 2; 0.23 mm – setting 4; 0.37 mm – setting 6) and settings 4
and 6 created scalloped excavation that was not present with setting 2. The authors
concluded that RF energy was safe to apply to fibrillated cartilage since no discernible
damage was created in the adjacent chondrocytes. In addition, the device was more
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efficient when used in a non-contact manner. It was felt that the smooth surface created
by RF application would help prevent further arthritis.
Lu et al. performed a similar project in which articular cartilage was treated with
bRF (ArthroCare – settings 2, 4, and 6) until the fibrillated cartilage explants had a
smooth surface.36

When examined with standard H&E staining the chondrocytes

appeared to have normal morphology; however, when the treated cartilage was stained
with safranin-O the uptake was decreased within the superficial layer, and a clear
demarcation was noted between the treated and untreated regions. In addition, CLM
revealed that RF energy created immediate chondrocyte death, and some of the damage
reached as deep as the subchondral bone (5 of 36 samples). It was also noted that as the
power setting increased the area of chondrocyte death was wider and deeper.
Ryan et al. assessed the amount of proteoglycan synthesis and degradation in the
articular cartilage of patellar explants from 11 horses following bRF treatment (Mitek –
20, 40, and 60 W).42 In addition, cell viability and histopathology were evaluated.
Chondromalacia was simulated on the patella, and the articular surface was treated with
bRF in a “paintbrush” fashion until the surface was smooth. It was noted that treatment
at all three settings significantly decreased proteoglycan synthesis, and the proteoglycan
degradation increased with higher power setting. Additionally, treatment at 40 and 60
watts of power significantly decreased cell viability to 81% and 73% of normal tissue,
respectively. All investigators concluded that increasing RF treatment energy levels
created a dose-dependent increase in chondrocyte morbidity and mortality regardless of
the testing modality.
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Temperature
Thermal heating was the suspected cause of the chondrocyte damage observed in
many of the RF investigations. In 2002, Edwards et al. used osteochondral sections from
the femoropatellar joint of adult cattle to study thermal effects on articular cartilage.38
Tip sensing fluoroptic thermocouples were placed at 200, 500, and 2,000 microns below
the articular surface. Both bRF (ArthroCare, CoVac 50 – setting 2) and mRF (Oratec,
TAC-C – setting 70ºC/30W) devices were tested with and without flow of saline at room
temperature (22ºC). Temperature created by the bRF device was found to be consistently
greater than the mRF device at all measured depths, regardless of fluid flow.
Temperatures greater than 75ºC were noted at all depths during bRF application, and
temperatures greater than 50ºC were noted at 200µm and 500µm below the surface
during mRF treatment. Flow of saline did not affect the temperature of bRF at 200µm or
2,000µm below the surface, but did decrease the temperature at 500µm below the
surface. When mRF was applied with fluid flow, greater temperatures were noted at
200µm and 500µm below the articular surface when compared to no fluid flow; however,
this was not evident at 2,000µm. The authors concluded that the dissipation of heat
created by the flow of irrigation fluids caused the temperature sensing probe in the mRF
tip to increase the power level of the generator in order to maintain a constant
temperature.38

Cook et al. evaluated the effects of temperature culture media on

chondrocytes and found that when the temperature was greater than 45ºC there was
significantly less cell viability 24 hours after treatment.43
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It appears that although temperatures decrease as the distance from the probe
increases within the articular surface, most temperatures created by RF are much greater
than the 45°C required to create severe chondrocyte damage.

These elevated

temperatures have been measured as far as 2 mm below the articular surface.
Testing Modalities
Many early studies of RF treatment used histological assessment and concluded
that no damage occurred to the chondrocytes or the matrix within the articular
cartilage.32,34,39 However, newer testing methods and special staining techniques have
challenged these conclusions.33,35,40 CLM, along with a live/dead cell staining technique,
has been use to assess chondrocyte viability even when cells appeared morphologically
normal on histological examination.33,36,38,40 The live/dead cell staining technique uses a
combination of calcein and ethidium homodimer. The cell membranes of dead, damaged,
or dying cells are penetrated by ethidium homodimer to stain the nuclei red. Living cells
with intact plasma membranes and active cytoplasm metabolize calcein and show green
fluorescence. All publications that have compared CLM to traditional hematoxylin and
eosin (H&E) staining have found that significantly greater chondrocyte death/damage is
detected with CLM immediately following RF application to the articular
cartilage.33,35,36,40

In addition, these authors have concluded that H&E may not be

sensitive enough to detect functional from non-functional chondrocytes with normal
histological morphology. Staining of the proteoglycan within the articular matrix with
safranin-O, Masson trichrom, or alcian blue has also found distinct decreases in stain
uptake within RF treated areas even when traditional light microscopy has indicated that

the chondrocytes have normal morphology.

33,36,38
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Since chondrocytes are known to

provide nutrition to the cartilage matrix, a decreased amount of proteoglycan staining
likely indicates a decrease in the viability of chondrocytes despite normal morphology
histologically. Therefore, when assessing acute damage of the articular cartilage, newer,
more sensitive testing modalities are required to assess chondrocyte viability.
Monopolar vs. Bipolar RF Devices
Lu et al. used fresh bovine osteochondral sections to test the differences between
bRF (Mitek, VAPR – setting V2:40 W; ArthroCare, 3.0mm/90º ArthroWand – setting 2)
and mRF (Oratec, TAC-C – setting 55º/25 W).37 Two separate treatment techniques were
used in this investigation. First, a single pass at 1mm/sec was used with all devices to
test the effects on the articular cartilage with and without contact between the probe and
the surface. Second, an area (10 x 10 mm) was abraded with a specially designed tool
and then treated in a “paintbrush” fashion to simulate clinical use. Scanning electron
microscopy (SEM) revealed that all surfaces were smooth following RF treatment.
However, when used in a contact manner, bRF resulted in significantly deeper
penetration (ArthroCare 100%; Mitek 125%) of the articular surface and significantly
more chondrocyte death (ArthroCare 128%; Mitek 100%) than the mRF (Oratec) device
when evaluated with CLM. Bipolar RF (Mitek and ArthroCare) also penetrated the
subchondral bone in nearly half (3 of 8) of the samples while mRF did not. When used in
a non-contact fashion, visual smoothing was noted with bRF, but mRF had no effect.
ArthroCare showed greater chondrocyte damage than Mitek with nearly all samples
showing penetration to the level of the subchondral bone (7 of 8 vs. 3 of 8). When the
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ArthroCare (bRF) device was used in a non-contact manner it led to 20% deeper and 25%
wider damage than when used in a contact fashion. When the abraded surface was
treated in a “paintbrush” manner, the bRF (ArthroCare 500%; Mitek 230%) treatment
times were much shorter than the mRF. Although significant chondrocyte death was
noted with all devices, bRF (ArthroCare 92%; Mitek 78%) penetrated the articular
surface to a greater extent than mRF. Bipolar RF also penetrated a portion of the
articular cartilage to the subchondral bone in all “paintbrush” treated samples where the
mRF did not.
Edwards et al. conducted a similar study with human osteochondral explants
obtained from patients undergoing total knee arthroplasty.35 All grade 2 or 3 cartilage
lesions were treated under arthroscopic visualization in a “paintbrush” fashion with either
bRF (ArthroCare, CoVac 50 – setting 2; Mitek, 3.5mm VAPR – setting V2:40W) or mRF
(Oratec, TAC-C – setting 70ºC/30W) energy until the articular surface was smooth.
Bipolar RF (24 seconds) smoothed the surface faster than mRF (39 seconds), but lead to
chondrocyte death at a significantly greater depth when evaluated with CLM
(ArthroCare=2228 µm; Mitek=2819 µm; Oratec 737 µm). Bipolar RF also reached the
subchondral bone in a significantly greater number of samples than the mRF
(ArthroCare=6 of 10; Mitek=7 of 10; Oratec 0 of 10).

Once again significant

chondrocyte death was seen with all treatment devices.
When comparing the two types of RF energy it becomes evident that bRF energy
results in greater treatment temperatures than mRF energy.

Although this leads to

decreased surgical time it also leads to significantly greater chondrocyte damage.
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Despite the large discrepancy in the amount of damage created by the two devices, it is
important to keep in mind that all devices created chondrocyte death when tested at the
manufacture’s recommended settings.
Chondromalacia Treatment
Turner et al. simulated chondromalacia in sheep and then subsequently managed
the lesion arthroscopically with either a mechanical shaving device or bRF energy.32
Animals were evaluated periodically for 6 months after surgery. Histologically, lesions
treated with RF had 14% favorable responses and 36% favorable or neutral responses.
The animals that received treatment with a mechanical shaving device had 0% favorable
and 7% favorable or neutral responses.

Additionally, chondrocyte damage to the

subchondral bone was not evident, histologically, in the RF treated specimens. It was
concluded that RF was superior to mechanical shaving.
Lu et al. performed a similar study in which they created a comparable lesion in
mature sheep and provided either: no treatment or were treated. The treated lesions
received mRF energy (Oratec, ORA-50 – setting 55ºC/15W) or were converted to a fullthickness lesion with curettage and microfracture.33 Animals were evaluated periodically
for 6 months after surgery. In addition to light microscopy all samples were evaluated
with CLM and SEM. Cell viability (CLM) was largely unchanged in the control group at
each time period. In contrast, the RF group had extensive chondrocyte death on day 0
that increased at week 2 and then remained constant throughout the remainder of the
study. The area treated with curettage and microfracture had completely filled with
fibrocartilage by week 24.

Histologically, detrimental effects were noted in the
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chondrocytes following RF treatment. The amount of chondrocyte damage and the lack
of proteoglycan staining continued to increase throughout the study. SEM revealed that
RF created a smooth surface that appeared to be melted at time 0 and continued to be
smooth throughout the experiment.

The authors concluded that the immediate

chondrocyte death and progressive decrease in proteoglycan staining would eventually
lead to complete loss of articular cartilage function despite the fact that the cartilage
matrix was maintained, and the surface continued to be smooth throughout the
experiment.
Gundel et al. compared the acute changes to the chondrocytes in the articular
cartilage of adult sheep treated with bRF or mechanical shaving after the creation of a
partial-thickness osteochondral lesion on the distal femoral condyle.39 Treatment groups
included: a rotary shaver; ArthroCare, CoVac 70; ArthroCare 2.5mm/90º; or no
treatment. Samples were analyzed with light microscopy (H&E) for surface morphology,
depth of tissue ablation, and amount of thermal damage. Lesions treated with RF showed
no appreciable difference between the two treatment wands. Smooth concave defects
with a variable amount of chondrocyte injury were noted adjacent to the defect, and the
matrix appeared unaltered.

The authors concluded that bRF had no immediate

deleterious effects on cartilage when applied in this fashion.
Owens et al. treated 48 consecutive female patients with isolated patellar cartilage
lesions who had failed a 6-month trial of conservative therapy.41 A shaving device was
used to mechanically debride the damaged cartilage, or bRF energy was use to smooth
the fibrillated cartilage. Prior to surgery all patients had crepitus within the stifle. At the
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2-year follow-up, 68% of the patients in the mechanical debridement group, compared to
only 45% of the patients in the RF group, still had crepitus. No significant difference was
noted between the two groups prior to surgery when a subjective scoring system for the
evaluation of the femoropatellar joint was used; however, statistically greater
improvement at both 1- and 2-year follow-ups was seen in patients that received RF
treatment.
Clinically, it appears that treatment of chondromalacia with RF creates a smooth
surface that is superior to the treatment with a mechanical shaving device as long as 2
years after surgery. However, severe, irreversible chondrocyte damage is created by the
RF energy at the time of surgery. This leads to the depletion of the extracellular matrix
that may eventually lead to the overall mechanical failure of the articular cartilage.
New Testing Modalities
Recently investigators have begun to assess the amount of proteoglycan synthesis
and degradation in the articular cartilage following RF treatment. Ryan et al. assessed the
amount of chondrocyte proteoglycan synthesis and degradation in the cartilage matrix of
equine patellar articular cartilage that was treated with bRF energy (Mitek – setting 20,
40, and 60 W).42 They found a significant decrease in proteoglycan synthesis following
treatment at all three energy levels.

In addition, proteoglycan degradation was

significantly increased at 40 and 60 watts of power. However, this study only evaluated
the acute effects of RF, and it is unclear as to whether this is an initial shock to the
chondrocytes or if there are long-term detrimental effects.

29
Cook et al. assessed the glycosaminoglycan (GAG) and collagen content, type II
collagen and matrix metalloproteinase (MMP)-13 immunoreactivity, and histopathology
of cultured cartilage explants on days 0, 5, 10, and 20 following bRF treatment (Mitek
90W).43 RF treated cartilage had reduced permeability and considerable histological
damage. Most treated samples also had reduced collagen type-II staining and increased
MMP-13 immunostaining. GAG content was largely unchanged throughout the study
except for the samples treated in a diffuse “paintbrush” fashion at day 20. Chondrocyte
viability was not significantly different between treatment groups.
CONCLUSIONS
Since the late 1990’s RF energy has become very popular in human and
veterinary arthroscopic surgery. RF energy is created at a similar frequency as AM
radiowaves, and thus it is referred to as radiosurgery or electrosurgery. Monopolar and
bipolar RF afford the surgeon a variety of options for the treatment of many orthopedic
injuries. RF devices are much less expensive than laser energy devices and allow for
greater control of collateral damage within the joint.
Application of RF energy leads to the immediate shrinkage of joint capsular
tissue. This shrinkage is both temperature and power dependent with higher settings
leading to greater tissue shrinkage. There does, however, appear to be a limit to the
amount of tissue shrinkage attainable. Greater power settings also lead to higher tissue
temperatures. However, tissue temperature decreases significantly as the distance from
the probe tip increases. Histologically, it appears that there is immediate damage to the
collagen and fibroblasts within the treated area.

Thermal heating of the collagen
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molecules leads to an unwinding of the normal triple helix and thus a loss of function.
Within two months, however, the treated area looks more normal, histologically and
ultrastructurally, as fibroblasts have filled the treated area with new collagen.
Mechanically, an initial loss in tissue stiffness is restored 6 to 12 weeks after surgery.
These mechanical changes coincide with the histological appearance of new collagen.
Because of this initial loss in mechanical strength, treated joint capsular tissue should be
protected for up to 12 weeks after application of RF energy.
Application of both bRF and mRF energy to the articular cartilage leads to
significant and immediate chondrocyte damage.

Increasing power leads to greater

chondrocyte damage within the articular cartilage. Chondrocyte damage begins to occur
at 45°C. When RF energy is used to directly treat the articular cartilage, all devices
create temperatures greater than 45°C within the articular cartilage when used at the
manufacture’s recommended settings. Bipolar RF works at a higher power than mRF
which leads to greater chondrocyte damage despite shorter surgical times. Clinically, it
appears that patients who received RF treatment of their fibrillated cartilage respond
more favorably than those that receive treatment with a mechanical shaving device.
CLM and proteoglycan staining are more sensitive to functional differences within RF
treated chondrocytes than traditional light microscopy. RF energy should be used with
caution until further studies are conducted to devise an optimum temperature and power
setting for arthroscopic use. If used, RF energy should be used at the lowest possible
setting, for the shortest amount of time, to achieve the desired effects.
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CHAPTER II
CHANGES IN RABBIT ARTICULAR CARTILAGE FOLLOWING TREATMENT
WITH BIPOLAR OR MONOPOLAR RADIOFREQUENCY ENERGY AND WITH OR
WITHOUT COSEQUIN® THERAPY
INTRODUCTION
Radiofrequency (RF) energy is routinely used in conjunction with arthroscopy to
shrink exuberant joint capsular tissue, cauterize blood vessels, treat meniscal injuries,
smooth fibrillated cartilage, debride frayed cruciate ligaments, and to perform medial
meniscal release during the repair of cranial cruciate ligament deficient stifles.
Arthroscopically-assisted tibial plateau leveling osteotomy (TPLO) is gaining popularity
and becoming a well-recognized treatment for cranial cruciate disease in large breed
dogs. During arthroscopic surgery, the RF probe is often used in close proximity to the
articular cartilage and, in some cases, may incidentally contact the cartilage surface,
possibly creating damage or death to the chondrocytes and extracellular matrix.
Numerous research projects have documented the changes in the articular
cartilage resulting from the use of RF energy to treat cartilage defects.1-13 Most of this
research, however, has focused on the acute effects of monopolar (mRF) or bipolar (bRF)
RF energy when applied directly to the cartilage surface (contact treatment).
Unfortunately, the results of these studies are conflicting and appear dependent on the
testing method used to detect cartilage injury. Kaplan et al. reported that cartilage treated
35
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with bRF energy had no histological difference than non-treated cartilage when evaluated
with a variety of staining techniques.1 They concluded that RF energy was safe for use
on articular cartilage. Studies in which articular cartilage was assessed with scanning
electron microscopy (SEM) following the use of RF energy found that the surface was
smooth and free from fibrillation or clefts when assessed up to 24 weeks following
surgery.2,3 However, Lu et al. and Edwards et al. reported that both mRF and bRF energy
led to immediate chondrocyte death when the cartilage was evaluated with confocal laser
microscopy (CLM) and a live/dead cell viability kit.2,4 When evaluation was completed
with CLM, chondrocyte death was observed as deep as the subchondral bone after direct
application of RF energy.2 In addition, bRF energy led to chondrocyte death 3-4 times
deeper than mRF energy.4 In another study, Lu et al. used both CLM and traditional light
microscopic techniques (H&E and safranin- O) to compare articular cartilage treated with
bRF energy.5 No morphologic differences were observed in the chondrocyte nuclei
stained with H&E in the RF treated cartilage. However, a clear demarcation between the
treated and untreated regions was seen with safranin-O staining, and significant
chondrocyte death was noted with CLM evaluation. Chondrocyte death was also noted to
increase when more RF energy was applied. From this information it appears that the
live/dead cell staining technique used with CLM may be superior to traditional light
microscopy when assessing chondrocyte function immediately after application of RF
energy.
To the author’s knowledge, Lu et al. is the only group to date to evaluate the longterm effects of RF energy on articular cartilage.3 A partial-thickness cartilage defect was
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created on the trochlea of adult female sheep. The created defects were then treated with
RF energy, converted to a full thickness lesion which was treated with curettage and
microfracture, or left untreated. In the cartilage treated with RF energy, immediate
chondrocyte death was noted with CLM.

Furthermore, histological analysis found

detrimental effects to the chondrocytes and proteoglycan concentration that progressed
over the 24 weeks of the study. Though fibrillation or cartilage clefts were not seen in
the RF treated tissues at 24 weeks, the authors concluded that the death of chondrocytes
and the decrease in proteoglycan staining would inevitably lead to degradation and loss
of cartilage function.
Recently, Cook et al. used in vitro techniques to study the cellular and
biochemical changes in articular cartilage treated with RF energy.6 It was noted that the
glycosaminoglycan (GAG) content was largely unchanged, type-II collagen was
significantly decreased, and matrix metalloproteinase (MMP)-13 was significantly
increased in the treated tissue. In addition, significantly less GAG was released from
diffusely treated cartilage when compared to focally treated cartilage.

Chondrocyte

cultures placed in tissue media greater than 45ºC were also found to have significantly
less cell viability than controls.
Lu et al. recently assessed fluid temperatures created when RF energy was used to
shrink joint capsular tissue in an artificially created joint.14

They noted that fluid

temperatures never exceeded 40ºC when tissue was treated under continuous flow at 200
mL/min. However, under no flow, treatment temperatures reached as high as 80ºC when
RF energy was applied continuously for 3 minutes. However, the thermometry probe
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used in this study was placed 1cm from the probe tip, and the joint was 25mL in size. It
is known that tissue temperature decreases as the distance from the probe tip
increases.7,15-17 Most joints evaluated in veterinary surgery have structures that are much
closer than 1cm from the probe tip; therefore, temperatures may reach much higher levels
than those found in this study. These higher temperatures could potentially lead to
chondrocyte damage in vivo.
Oral supplements containing glucosamine hydrochloride and chondroitin sulfate
are reported to have a chondroprotective effect on cartilage and are commonly used to
treat a variety of joint abnormalities in humans and animals.18-28 Cosequin ® (Cosamin
®) is a commercially available brand of glucosamine hydrochloride and chondroitin
sulfate that is often prescribed for use in dogs, horses, and humans. In vitro studies have
supported the role of glucosamine as a modulator of cartilage metabolism that improves
cartilage integrity through the stimulation of proteoglycan production.18-20 Chondroitin
sulfate, the most abundant GAG in the body, is especially important in articular (hyaline)
cartilage as it aggregates with hyaluronic acid, other GAGs, and proteins to form
proteoglycan macromolecules. These aggregate chains bind with collagen to form the
characteristic resilient matrix of articular cartilage.21 Studies have shown exogenous
chondroitin sulfate can decrease interleukin-1 production, block complement activation,
and competitively inhibit MMPs, thereby slowing degradation of cartilage and other joint
tissue.19,20 Other studies have shown, when Cosamin® DS was used in a rabbit stifle
instability model, a significant decrease in the amount of moderate and severe cartilage
lesions when treated rabbits were compared to those that did not receive treatment.22,23 A
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recent survey of small animal practitioners found that the average onset time to observed
clinical efficacy following administration of glucosamine and chondroitin sulfate was
approximately four weeks.24 Although unproven, many investigators believe that the best
results for chondromodulation are achieved in patients that do not have severe structural
changes in the articular cartilage, and when viable chondrocytes are still present.25,26 To
date, the possible protective effects of glucosamine hydrochloride and chondroitin sulfate
on articular cartilage have not been evaluated in patients undergoing arthroscopic surgery
with RF treatment.
Currently, the short and long-term effects of mRF and bRF energy on the
biomechanical properties and metabolic activity of the articular cartilage is controversial
and requires further investigation. Additionally, the effect that RF energy has on articular
cartilage when used in the joint to treat surrounding structures, without contacting the
articular surface, has not been fully described. This study will document the effects on
the biomechanical properties and metabolic activity of the articular cartilage following
the remote use of mRF and bRF energy on the soft tissues within the stifle joint of
rabbits. It will also evaluate the protective effects of Cosequin®, if any, on articular
cartilage when RF energy is used during arthroscopic surgery.
MATERIALS AND METHODS
Experimental Animals
Thirty, New Zealand White rabbits were randomly assigned to one of two
treatment groups. Group-1 consisted of 15 rabbits that received a normal rabbit diet

(placebo) for 4 weeks prior to surgery and throughout the study period.
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Group-2

consisted of 15 rabbits that received Cosequin® (2% by body weight) daily mixed into
the food at processing for 4 weeks prior to surgery and throughout the study period. Each
rabbit was subjected to arthroscopic stifle surgery using either mRF or bRF energy. This
project was approved by the animal care and use committee at Mississippi State
University.
Surgery
On the day of surgery, each rabbit was premedicated with ketamine (10 mg/kg
body weight), midazolam (0.1 mg/kg body weight), and buprenorphine (0.015 mg/kg
body weight), intramuscularly. An intravenous catheter was placed in the marginal ear
vein prior to anesthetic induction, and Lactated Ringer’s Solution (10 ml/kg/hr) was
administered.

Anesthesia was induced with mask induction and maintained with

isoflurane in oxygen following endotracheal intubation. Both stifles were clipped and
prepared for aseptic surgery.

In one stifle joint (randomly selected), a 1.9 mm

arthroscope with camera attached (Richard Wolf, 25°, 1.9mm Needle arthroscope with
telescope, Medical Instruments Corp., Vernon Hills, Illinois) was inserted via a standard
lateral portal and connected to a xenon light source (Richard Wolf, 180 W, Xenon Auto
LP 5123 Light Source, Medical Instruments Corp., Vernon Hills, Illinois) and fluid
pump. A medial instrument portal was then created. The infrapatellar fat pad was
partially excised with a mechanical shaving device (Richard Wolf, Power Stick M3,
Medical Instruments Corp., Vernon Hills, Illinois) to allow visualization of the distal
femoral condyles. Then, under arthroscopic visualization, a mRF wand (Vulcan Micro
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Ablator, 70ºC/40W, ORATEC Interventions, Inc., Menlo Park, California) was inserted
through the instrument portal into the joint. The RF wand was then used for a total of 45
seconds in short (5-10 second) bursts to further remove the infrapatellar fat pad. A stop
watch was used to record the total time the RF energy was applied. Taking care not to
contact the articular surface, the wand was used in a “paintbrush-like” fashion. The
instrumentation was removed, and the portals were closed with tissue glue. The same
procedure was then performed on the contralateral stifle joint using a bRF wand
(ArthroCare System 2000, Microblator 30 probe, ArthroCare Corp., Sunnyvale,
California) on setting 2. Treatment devices were randomly assigned to each stifle (right
vs. left) and each time (first vs. second). Total surgery time was recorded.
The rabbits were given meloxicam (0.5 mg/kg body weight, PO q 12 hr) during
anesthetic recovery and, as needed, for the first 3 days postoperatively to control pain and
inflammation. The rabbits were housed individually and allowed to exercise freely in
their cages throughout the study period.
Sample Collection
Five rabbits from each group were humanely euthanatized on day 0 following
surgery and at 4 and 14 weeks after surgery. The stifle joints were harvested bilaterally.
Samples were also collected from unoperated hip joints and processed in the same
manner to serve as controls for cell viability evaluation. A low-speed saw (Isomet Plus,
Buehler Ltd., Lake Bluff, Illinois) was used to cut the distal femoral condyles into four
equal osteochondral blocks. Phosphate-buffered saline (PBS) irrigation was used during
cutting to prevent frictional heating of the samples. The four osteochondral blocks
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collected from each joint were used for either histopathologic evaluation, analysis of cell
viability (CLM), biomechanical testing, or evaluation of metabolic activity (GAG
synthesis) within the treated cartilage.
Histopathology
The osteochondral blocks used for histopathologic evaluation were fixed in 10%
neutral-buffered formalin, decalcified with Kristensen’s solution, and sectioned prior to
embedding in paraffin. Samples were then cut into 5µm thick sections and stained with
hematoxylin and eosin to evaluate chondrocyte cytoplasmic and nuclear morphometry
and shape.

Adjacent sections were then stained with safranin-O to evaluate the

proteoglycan within the extracellular matrix. Samples were evaluated with a modified
Mankin scoring system to detect differences between the treatment groups relative to
percent area of cartilage affected; necrosis of the superficial, intermediate, and deep
cartilage layers; hyalinization of the matrix; and loss of safranin-O staining. (Figure 1)
During evaluation, the area with the greatest damage was scored. Scores recorded for
each criteria were then added together to create a total histological score. All samples
were evaluated by two pathologists blinded to the treatment group from which the
samples were collected. Mean scores from the two pathologists were used for analysis.
Cell Viability
The osteochondral blocks used to assess chondrocyte viability were placed in
physiologic buffered saline (PBS) until testing with confocal laser microscopy. Testing
was completed within four hours of the rabbits being euthanized. The osteochondral
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Modified Mankin Scoring System
Percent area of cartilage affected
0 = none
1 = 10-30%
2 = 30-60%
3 = 60-100%
Necrosis of chondrocytes in superficial layer
0 = absent
1 = mild
2 = moderate
3 = severe
Necrosis of chondrocytes in intermediate layer
0 = absent
1 = mild
2 = moderate
3 = severe
Necrosis of chondrocytes in deep layer
0 = absent
1 = mild
2 = moderate
3 = severe
H & E (Hyalinization of extracellular matrix)
0 = absent
1 = mild
2 = moderate
3 = severe
Safranin-O (Loss of staining)
0 = absent
1 = mild
2 = moderate
3 = severe
Total Histopathologic Score
0 (normal) – 18 (complete loss)
Figure 1 – Modified Mankin Scoring System
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blocks were removed from the PBS solution and incubated with 1.0 mL of PBS
containing 0.4 µL calcein (acetoxymethylester) per 13 µL ethidium homodimer
(Live/Dead Viability/Cytotoxicity Kit [L-3224], Molecular Probes, Eugene, Oregon) for
30 minutes at room temperature.

The ethidium homodimer penetrates the cell

membranes of dead, damaged, or dying cells and stains the nuclei red. Living cells with
intact plasma membranes and active cytoplasm metabolize the calcein and fluoresce
green.

All samples were examined with a confocal laser microscope (Leica

Microsystems Inc., Exton, Pennsylvania) equipped with an argon laser and the necessary
filter systems to assess the depth of chondrocyte death created by the RF energy.
Measurements of the cartilage thickness and the depth of chondrocyte death were
acquired in three separate sites within the samples to determine the percentage of
cartilage damage. The mean of the three measurements was used for statistical analysis.
All samples were evaluated without knowledge of the treatment each received. Samples
collected from untreated hips (controls) were incubated and measured in the same
manner.
Biomechanical Testing
The osteochondral segments used for mechanical testing were wrapped in a saline
moistened paper towel and stored at -70ºC until the time of testing. On the day of testing,
the osteochondral segment was thawed at room temperature and mounted to the custom
testing jig with cyanoacrylate glue. The cartilage and underlying subchondral bone
underwent compressive indentation testing on a stepper motor-driven micromechanical
testing machine (Mach-1, Biosyntech, Montreal, Canada) stationed in a 37ºC incubator.
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Prior to testing, the samples were submerged in 37ºC saline and allowed to equilibrate for
10 minutes. Samples were subjected to a 5-segment stress relaxation test. Each segment
was composed of a 30µm ramp indentation at 15µm/second.

This position was

maintained until the slope of the force verses time curve fell below 1 gram/minute. The
force at this point was used to calculate equilibrium stress, and the test immediately
proceeded to the next segment. Thus the total indentation was 150µm, achieved in a
stepwise fashion with stress relaxation occurring at each step. Equilibrium stress was
plotted against applied strain, and the slope of this curve was taken as the equilibrium
compressive modulus. The equilibrium compressive modulus was recorded at three
separate, random locations within each sample. All indentions were made perpendicular
to the cartilage surface. All samples were tested by the same individual who was blinded
to the diet and device used.
After indentation testing was completed, osteochondral bone blocks were
decalcified and sliced (perpendicular to the surface) through the testing sights which were
previously marked with a tissue dye. Cartilage slices were digitally photographed next to
a ruler with 1-mm gradations. Imaging software (Scion Image, Scion Corp., Frederick,
Maryland) was used to calculate the thickness of the cartilage. Measurements were
performed manually using a line tool, with the scale set using the ruler marks. Five
separate measurements were taken at each testing location and averaged to acquire the
cartilage thickness at each site. These cartilage thickness measurements were used in the
calculation of strain (displacement divided by cartilage thickness).

46
Metabolic Activity
A stock solution of culture media was made by placing 50mL of adult bovine
serum into a 500mL vial of Ham’s nutrient mixture. One milliliter of the culture media
was placed into each well of a 24-well plate. The cartilage from the final osteochondral
block was removed from the subchondral bone with a scalpel blade and place
individually in the wells for transportation prior to digestion. GAG synthesis testing was
performed as previously described.29 Briefly, the cartilage samples were incubated for 4
hours at 37°C in a medium containing 20 µCi/mL
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S aqueous sulfate. Radioactive

medium was removed and replaced with 500µL detergent lysis buffer.

DNA was

quantified from an aliquot of the lysis buffer using the Hoescht dye procedure (DNA-QF,
Sigma-Aldrich, St. Louis, Missouri) using a Vicam Series 4 fluorometer with calf thymus
DNA as a standard.

Residual lysis buffer was removed and replaced with 1%

weight/volume papain in 50 mM sodium acetate (pH = 6). Samples were incubated
overnight at 60ºC, and the macromolecular
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S was separated from unincorporated label

using sephadex desalting columns (PD-10 columns, Amersham Biosciences, Pittsburg,
Pennsylvania). Four milliliters of scintillation fluid was added to each elution fraction,
and radioactivity was determined by liquid scintillation counting (Beckman Coulter
Scintillation Counter, GMI, Inc., Albertville, Minnesota). Macromolecular incorporation
was taken as the area under the first peak of the elution curve.

Incorporation, in

disintegrations per minute (DPM), was normalized to DNA content. All samples were
tested without knowledge of the diet or device used.
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Statistical Analysis
The effects of Cosequin, type of RF probe, and time after surgery on measures of
cartilage health were analyzed using a mixed model analysis of variance (ANOVA) for a
repeated measures design with one within-subject factor and two between-subjects
factors in a factorial arrangement. The within-subject factor was the type of RF probe
(mRF vs. bRF), and the between-subjects factors were the drug regimen (Cosequin vs.
placebo) and the time after surgery (0, 4, and 14 weeks). The ANOVA was performed
using the SAS procedure MIXED.30 If significant effects were found, means were
separated using the least significant difference test.

The clinical importance of

statistically significant differences were assessed using confidence intervals.31

The

percentage of chondrocyte death (0-25, 26-50, 51-75, >75%) was further divided into
four subgroups and analyzed using Fisher’s exact test. All calculations were performed
using the SAS System for Windows, Version 9.1 (SAS Institute Inc., Cary, North
Carolina); all statistical tests used the 0.05 level of significance.
RESULTS
Rabbits weighed an average of 3.7 kg (range, 3.2 – 4.1 kg) in group-1 (normal
diet) and 3.7 kg (3.2 – 4.3 kg) in group-2 (Cosequin® therapy). The average total
surgery time for rabbits in group-1 was 30.4 minutes (range, 15 – 81 min.) and 31.3
minutes (14 – 82 min.) in group-2. The total time that the probe was activated within the
joint was 45.6 seconds (range, 44.6 – 46.4 sec.) in group-1 and 45.5 seconds (44.8 –
46.12 sec.) in group-2. No significant differences were noted between group-1 and
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group-2 with respect to the weight of the rabbits (p = 0.86), total surgery time (p = 0.47),
or the total time the RF probe was used in each joint (p = 0.49).
Histopathology
Percent Area of Cartilage Affected: (Figure 2) A significant interaction was
found between diet (group) and device (type of RF; p = 0.02). There was significantly
less cartilage affected in group 2 compared to group 1 when bRF energy was used. There
was no significant difference between diet groups when mRF energy was used.
A significant interaction was also found between time (0, 4, and 14 weeks) and
device (p = 0.03). In joints treated with bRF, the percent area of the cartilage affected
was significantly greater at weeks 4 and 14 than at week 0, irregardless of diet. The
percent area affected was not significantly different between weeks 4 and 14. In joints
treated with mRF, the percent area of cartilage affected was significantly greater at 14
weeks than at weeks 0 and 4, irregardless of diet. There was no significant difference
between weeks 0 and 4.

At week 14, the percent area of cartilage affected was

significantly less in group-2 rabbits treated with bRF than in group-1 rabbits treated with
bRF or group-2 rabbits treated with mRF (p< 0.05).
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Percent Area of Cartilage Affected
Diet and Device vs. Time
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Figure 2 – Percent Area of Cartilage Affected
Each diet and device is graphed over time.
Group-1, bRF=grey; Group-1, mRF=white;
Group-2, bRF=striped; Group-2, mRF=black.
Within each time point, means followed by the same lowercase letter are not
significantly different at p=0.05. Within each treatment group, the same
capital letters are not significantly different at p=0.05.
Necrosis of Chondrocytes in Superficial Layer of Articular Cartilage: A
significant three-way interaction was found with diet, time, and device (p = 0.046).
(Figure 3) Rabbits in group-1 treated with bRF had significantly more necrosis in the
superficial layer of the articular cartilage at week 14 than at week 0 (p<0.05).
There was no significant difference between week 0 and week 4 or between week
4 and week 14. Rabbits in groups-2 treated with bRF had significantly more necrosis in
the superficial layer at week 4 than at weeks 0 and 14 (p<0.05). There was no significant
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difference between weeks 0 and 14. When mRF was used, no significant differences
were noted in chondrocyte necrosis of the superficial cartilage layer in either group at any
time period. At week 14, chondrocyte necrosis in the superficial cartilage layer was
significantly less in group-2 rabbits treated with bRF than in group-1 rabbits treated with
bRF or group-2 rabbits treated with mRF (p< 0.05).

Necrosis of Chondrocytes in Superficial Layer of Articular Cartilage
Diet and Device vs. Time
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Figure 3 – Necrosis of Chondrocytes in Superficial Layer of Articular Cartilage
Each diet and device is graphed over time.
Group-1, bRF=grey, Group-1, mRF=white;
Group-2, bRF=striped; Group-2, mRF=black.
Within each time point, means followed by the same lowercase letter are not
significantly different at p=0.05. Within each treatment group, the same
capital letters are not significantly different at p=0.05.
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Necrosis of Chondrocytes in Intermediate Layer of Articular Cartilage:
(Figure 4) A significant difference was found in the amount of necrosis in the
intermediate cartilage layer over time (p=0.004), regardless of diet and device.
Chondrocyte necrosis was significantly greater at weeks 4 and 14 than at week 0.
Necrosis was not significantly different between week 4 and week 14. When bRF was
used in group-1 rabbits, necrosis in the intermediate zone was significantly greater at
week 14 than at week 0 (p<0.05); however, there were no differences between week 0
and week 4 or between week 4 and week 14. When bRF was used in group-2 rabbits,
necrosis in the intermediate zone was significantly greater at week 4 than at weeks 0 and
14 (p<0.05). When mRF was used, no significant differences were noted in chondrocyte
necrosis of the intermediate cartilage layer in either group at any time period. The only
significant difference found in the amount of necrosis present within the intermediate
layer of cartilage between mRF and bRF energy was noted at week 14 when significantly
less chondrocyte necrosis was found in group-2 rabbits treated with bRF than in group-1
rabbits treated with bRF or group-2 rabbits treated with mRF (p< 0.05).
Necrosis of Chondrocytes in Deep Layer of Articular Cartilage: A significant
interaction was found in the amount of chondrocyte necrosis in the deep layer of the
articular cartilage between diet and device (p = 0.04). (Figure 5)

Necrosis was

significantly greater at week 14 in group-1 rabbits treated with bRF when compared to
week 0 (p<0.05); however, there were no difference between weeks 0 and 4 or between
weeks 4 and 14. At week 14, chondrocyte damage in the deep layer was significantly
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greater in the group-1 rabbits treated with bRF than group-1 rabbits treated with mRF and
group-2 rabbits treated with bRF (p<0.05).

Necrosis of Chondrocytes in Intermediate Layer of Articular Cartilage
Diet and Device vs. Time
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Figure 4 – Necrosis of Chondrocytes in Intermediate Layer of Articular Cartilage
Each diet and device is graphed over time.
Group-1, bRF=grey; Group-1, mRF=white;
Group-2, bRF=striped; Group-2, mRF=black.
Within each time point, means followed by the same lowercase letter are not
significantly different at p=0.05. Within each treatment group, the same
capital letters are not significantly different at p=0.05.
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Necrosis of Chondrocytes in Deep Layer of Articular Cartilage
Diet and Device vs. Time
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Figure 5 – Necrosis of Chondrocytes in Deep Layer of Articular Cartilage
Each diet and device is graphed over time.
Group-1, bRF=grey; Group-1, mRF=white;
Group-2, bRF=striped; Group-2, mRF=black.
Within each time point, means followed by the same lowercase letter are not
significantly different at p=0.05. Within each treatment group, the same
capital letters are not significantly different at p=0.05.
Hyalinization of Extracellular Matrix: A significant interaction was noted
between diet and time (p = 0.02). (Figure 6) In group-1, there was significantly more
hyalinization, which correlates with more proteoglycan destruction, at weeks 4 and 14
than at week 0, but there was no difference between weeks 4 and 14. In group-2, there
was significantly greater hyalinization of the matrix at week 4 than at weeks 0 and 14;
however, weeks 0 and 14 were not significantly different from one another.
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Hyalinization of the Extracellular Matrix
Diet and Device vs. Time
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Figure 6 – Hyalinization of the Extracellular Matrix
Each diet and device is graphed over time.
Group-1, bRF=grey; Group-1, mRF=white;
Group-2, bRF=striped; Group-2, mRF=black.
Within each time point, means followed by the same lowercase letter are not
significantly different at p=0.05. Within each treatment group, the same
capital letters are not significantly different at p=0.05.
When bRF was used in group-1 rabbits, significantly greater hyalinization was
present at week 14 than at weeks 0 and 4 (p<0.05). When bRF was used in group-2
rabbits, significantly greater hyalinization was present at week 4 than at weeks 0 and 14
(p<0.05).

When mRF was used, no significant differences were noted in matrix

hyalinization in either group at any time period. There was no significant difference in
hyalinization caused by mRF and bRF at any time period. Hyalinization of the cartilage
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at week 14 was significantly greater in group-1 rabbits treated with bRF when compared
to group-2 rabbits treated with bRF (p<0.05).
Loss of Safranin-O Staining: A significant three-way interaction was found
between diet, time, and device (p=0.02). (Figure 7) Group-1 rabbits treated with bRF had
significantly less stain uptake at week 14 when compared to weeks 0 and 4 (p<0.05).
Group-2 rabbits treated with bRF had significantly less stain uptake at week 4 when
compared to weeks 0 and 14 (p<0.05).

Group-2 rabbits treated with bRF had

significantly more staining at week 14 than group-1 rabbits treated with mRF and group2 rabbits treated with mRF (p<0.05).
Total Histological Score: When all scores were combined to create a total
histological score, there was a significant difference over time, regardless of diet or
device, (p = 0.0004). (Figure 8) Total histological scores were significantly greater at
weeks 4 and 14 when compared to week 0. There was also a significant interaction
between diet and device (p = 0.046).
Group-1 rabbits treated with bRF had a significantly greater total histological
score at week 14 than week 0 (p<0.05), but week 4 was not different than the other two
time points. Group-2 rabbits treated with bRF had significantly higher total histological
scores at week 4 than weeks 0 or 14 (p<0.05); however, week 0 was not significantly
different from week 14. Group-2 rabbits treated with bRF had a significantly lower total
histological score at week 14 than group-1 rabbits treated with mRF and group-2 rabbits
treated with mRF (p<0.05).
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Loss of Safranin-O Staining
Diet and Device vs. Time
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Figure 7 – Loss of Safranin-O Staining
Each diet and device is graphed over time.
Group-1, bRF=grey; Group-1, mRF=white;
Group-2, bRF=striped; Group-2, mRF=black.
Within each time point, means followed by the same lowercase letter are not
significantly different at p=0.05. Within each treatment group, the same
capital letters are not significantly different at p=0.05.
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Total Histological Score
Diet and Device vs. Time
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Figure 8 – Total Histological Score
Each diet and device is graphed over time.
Group-1, bRF=grey; Group-1, mRF=white;
Group-2, bRF=striped; Group-2, mRF=black.
Within each time point, means followed by the same lowercase letter are not
significantly different at p=0.05. Within each treatment group, the same
capital letters are not significantly different at p=0.05.
Cell Viability
The thickness of the cartilage samples evaluated at each time period was not
significantly different between the type of RF energy used or the type of diet fed. Depth
of chondrocyte death was significantly greater in treated stifle joints than in control hip
joints (p=0.01). The average depth of chondrocyte death (±SE) was 17.58µm (±23.38µm)
for the control samples, 94.52µm (±15.61µm) for bRF samples, and 102.72µm
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(±15.61µm) for mRF samples, regardless of time or diet. There was no statistically
significant difference in the depth of chondrocyte death caused by mRF and bRF. There
was no statistically significant difference in the depth of chondrocyte death between
group-1 and group-2 at any time period.
The percentage of chondrocyte death (relative to total cartilage thickness) was
significantly greater in treated stifle joints than in control hip joints (p=0.007). The
average percent of chondrocyte death (±SE) was 4.05% (±3.94%) for the control
samples, 17.93% (±2.63%) for the bRF samples, and 18.88% (±2.63%) for the mRF
samples. There was no statistically significant difference in percentage of chondrocyte
death caused by mRF and bRF. (Figure 9)

There was no statistically significant

difference in the percentage of chondrocyte death between group-1 and group-2 at any
time period. The percentage of chondrocyte damage was further broken down into four
subgroups (0-25, 26-50, 51-75, and >75%) and analyzed with Fischer’s exact test. No
significant differences were noted with respect to diet, time, or device. Forty-nine of the
56 samples available for testing had chondrocyte damage between 0 and 25% of the
cartilage thickness. Four samples were unable to be analyzed due to sample collection
error (two rabbits from each diet and device at time 0).
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Cell Viability
Diet and Device vs. Time
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Figure 9 – Cell Viability
Each diet and device is graphed over time.
Group-1, bRF=grey; Group-1, mRF=white;
Group-2, bRF=striped; Group-2, mRF=black.
No significant differences were noted with respect to diet, time, or device.
Biomechanical Testing
There was a significant difference found in equilibrium compressive modulus
over time when all samples were combined (p = 0.014). (Figure 10) The compressive
modulus at week 4 was significantly less than week 14, but neither time was different
from week 0. There was no difference between group-1 and group-2 at any time period.
There was not difference between cartilage treated with mRF and cartilage treated with
bRF energy at any time period.

60
Biomechanical Testing
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Figure 10 – Biomechanical Testing
Each diet and device is graphed over time.
Group-1, bRF=grey; Group-1, mRF=white;
Group-2, bRF=striped; Group-2, mRF=black.
No significant differences were noted with respect to diet or device.
Values at 4 weeks were significantly less than 14 week; however, no
significant differences between weeks 4 and 14 when compared to week 0.
Metabolic Activity
There were no significant interactions between diet, device, or time when the
amount of GAG synthesis was evaluated. (Figure 11) GAG synthesis was significantly
greater in group-1 rabbits treated with bRF at week 4 when compared to week 14
(p<0.05); however, neither time was significantly different than time 0. At 4 weeks,
GAG synthesis was significantly greater in the group-1 rabbits treated with bRF than in
group-1 rabbits treated with mRF and group-2 rabbits treated with bRF (p<0.05).

61
Metabolic Activity
Diet and Device vs. Time
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Figure 11 – Metabolic Activity
Each Diet and Device is graphed over time.
Group-1, bRF=grey; Group-1, mRF=white;
Group-2, bRF=striped; Group-2, mRF=black.
Within each time point, means followed by the same lowercase letter are not
significantly different at p=0.05. Within each treatment group, the same
capital letters are not significantly different at p=0.05.
DISCUSSION
Arthroscopic surgery is commonly used by human orthopedic surgeons, and its
use is growing rapidly in veterinary surgery. Many investigators have reported the direct
effects of RF energy on the articular cartilage1-13 and the joint capsular tissue,14-17,32-42
independently.

However, to the author’s knowledge, the current literature does not

contain any documentation of the changes that occur in the articular cartilage following
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the remote treatment of the soft tissues in the joint with RF energy. Lu et al. recently
reported the fluid temperatures created in the joint during capsular shrinkage with RF
energy,14 and Cook et al. reported that cartilage explants incubated in culture media
greater than 45ºC lead to chondrocyte death;6 however, the biological response of
chondrocytes subjected to indirect RF energy is still unknown.

This investigation

simulated clinical use of both bRF and mRF energy, at tissue ablative settings, to describe
the changes in the articular cartilage following RF treatment of the soft tissues within the
joint.
In the study reported here, confocal laser microscopy (CLM) identified significant
chondrocyte death in the treated cartilage samples immediately after surgery.
Chondrocyte death was evident in the samples from the treated stifle joints; however, the
control samples, collected from untreated hip joints, were free of chondrocyte injury.
This indicates that the cell death in this study was a result of RF treatment and not a result
of the sampling technique used. This chondrocyte death was evident even though the RF
energy was applied to the soft tissues in the joint and not directly to the cartilage. This is
consistent with other reports in which significant loss of chondrocyte viability was noted
immediately after direct application of RF energy to the cartilage.2-6,12
Radiofrequency-associated chondrocyte death

occurred primarily in the

superficial portion of the articular cartilage (outer 25% of the total cartilage thickness) in
this investigation. This was true in the majority (49 of 56) of the samples evaluated, and
this damage remained consistent over the 14 weeks of the study. Other studies evaluating
the effects of RF energy following direct cartilage treatment have found full thickness

cartilage injury to the level of the subchondral bone.

2,4,5
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The more superficial injury

noted in this study is likely because the RF energy was used within the joint but was not
applied directly to the cartilage surface. Another factor may have been the duration of RF
treatment. In this study, RF energy was applied in 5 to 10 seconds bursts for a total of 45
seconds, under continuous lavage with lactated Ringer’s solution to maintain adequate
joint distention. This is consistent with the clinical use of RF energy to address synovial,
meniscal, or joint capsular disease. Time has been shown to be directly proportional to
the heat generated by RF energy, and thus longer application of RF would be expected to
cause chondrocyte death to greater depths.14,16,32 In addition, continuous flow of fluid has
previously been shown to reduce temperatures within the joint, and this could further
minimize the degree of cartilage injury.7,14 It is important to note that the depth of
chondrocyte death and the percentage of dead chondrocytes did not increase after the
initial RF treatment (week 0). This indicates that the injury sustained was immediate, and
no residual effects were present to cause continued cell death following the
discontinuation of RF treatment.
Despite the death of chondrocytes in the superficial portions of the cartilage, only
minor changes were detected in the extracellular matrix over the 14 weeks of the study.
Matrix hyalinization and loss of safranin-O staining were both increased at weeks 4 and
14 (when compared to week 0); however, there was not a difference between weeks 4 and
14 suggesting that the initial decrease in proteoglycan content was not progressive. In
another study, Lu et al. evaluated articular cartilage subjected to RF energy and noted
that, though cell viability remained constant, safranin-O staining of the proteoglycans

within the matrix continued to decrease throughout the 24 weeks of the study.

3
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The

authors concluded that the extracellular matrix would likely continue this depletion until
the mechanical function of the cartilage was eventually lost. In general, however, no
significant difference in the amount of GAG synthesized by the treated cartilage was
found in this study between the samples obtained 4 and 14 weeks after surgery. In
addition, the equilibrium compressive modulus of the RF treated cartilage at weeks 4 and
14 was not significantly less than week 0, indicating that the cartilage did not deteriorate
mechanically. These finding suggest that, despite the injury caused by the RF energy to
the superficial layer of the articular cartilage, the remaining chondrocytes were able to
maintain GAG synthesis and mechanical function over the 14 weeks of the study. This
may be attributable, in part, to the fact that the injury was superficial, and approximately
75% of the chondrocytes in the articular cartilage remained viable throughout the study.
In addition, more time may be required for significant matrix depletion to occur. An
evaluation of longer duration is warranted to address the issue of matrix health following
RF treatment. The rabbits used in this study were also confined to a cage throughout the
investigation. Studies evaluating the effects of exercise on RF treated cartilage would
help determine if the injury noted in this investigation is more detrimental than was
described.
This study also found that the effects created in the articular cartilage by mRF and
bRF energy were similar when used to treat the soft tissue in the joint. This finding
differs from others who have reported that bRF leads to the production of significantly
higher tissue temperatures and significantly greater chondrocyte destruction.2,4,7 The fact
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that both devices caused similar injury to the cartilage may be because both were set at
the level recommended for tissue ablation (e.g., treatment of damaged meniscus) and may
have created similar treatment temperatures within the joint. Temperatures greater than
45ºC have previously been reported to damage articular chondrocytes.5,6 In the study
reported here, the temperature within the joint fluid or articular surface was not recorded
during RF application. It would have been difficult to ensure that the distance from RF
probe to the thermometer was identical throughout the RF application, that the
thermometer was accurately placed in a consistent manner within the small stifle joints,
and that the thermometer was not dislodged during the arthroscopy procedure. However,
previous investigations have documented the tissue and fluid temperatures expected by
direct application of RF energy at various settings.3,7,14-17 Lu et al. found that when RF
energy was used in an artificial joint to shrink joint capsular tissue either continuously for
three minute or intermittently (on for 10 seconds and off for 5 seconds for 5 treatments)
the fluid temperature never exceeded 40ºC, as long as there was continuous fluid flow
(200mL/min).14

However, the temperature recording device used in that study was

placed 1cm from the tip of the RF probe. A previous investigation documented that
temperature exponentially decreased as the distance (r) from the RF probe tip increased
(1/r4).42 In addition, the temperature created by the RF probe was directly proportional to
the intensity (I) and the time (T) that the RF probe was in use, (I2T).42 Thus, higher
temperatures have been measured closer to the probe tip.7,15-17 In the study reported here,
because of the small size of the rabbit stifle joints, all tissue structures were less that 1cm
from the RF probe tip. In addition, the artificial joint used in the study by Lu et al. held
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25mL of fluid; significantly more than the rabbit stifle. In order to minimize tissue
temperature, yet accurately simulate the clinical use of RF energy to debride a damaged
meniscus or shrink a stretched joint capsule, RF treatment was applied intermittently (510 second bursts) for a limited time (total of 45 seconds) under continuous fluid flow.
The RF devices in this investigation were used at settings very similar to those employed
by Lu et al., (Oratec, 75ºC/40 W; ArthroCare, setting 2).14 However, with the small size
of the joints in our study, it is possible that fluid temperatures created would have
exceeded 45ºC and led to the changes noted in the articular chondrocytes.
Cartilage injury in rabbits fed Cosequin® before and after RF treatment was
similar to that seen in rabbits given a regular diet throughout this study. The fact that
supplementation with Cosequin was not shown to have a protective effect, or to
encourage cartilage repair in the 14 weeks of the study, may be attributable to the severity
and type of cartilage injury caused by the RF treatment. As demonstrated using CLM,
RF treatment caused immediate chondrocyte death, particularly in the superficial portion
of the cartilage, which persisted throughout the study. The proposed mechanism of
chondromodulation by glucosamine and chondroitin sulfate (Cosequin®) requires viable
chondrocytes.25,26 Therefore, the dead chondrocytes in this study would not be expected
to benefit from Cosequin® therapy. In addition, the amount of GAG synthesized by the
chondrocytes in this investigation did not significantly decrease at weeks 4 and 14
(compared to week 0) despite the death of the superficial chondrocytes. It is important to
note that serum or synovial glucosamine and chondroitin sulfate levels were not
measured in this study. Thus, we cannot confirm that rabbits fed a diet containing 2%
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Cosequin®, by body weight, actually had levels greater than those of control rabbits.
The dose used in this investigation was based on a previous study in which moderate and
severe cartilage damage was significantly decreased in rabbits with stifle instability fed
2% Cosamin®.22,23 Interestingly, significant improvement in many of the histological
parameters (percent area of cartilage affected, necrosis of the superficial and intermediate
layers of articular cartilage, hyalinization of the extracellular matrix, safranin-o staining,
and total histological score) were noted at week 14 in rabbits fed 2% Cosequin®.
However, these findings were not corroborated with GAG synthesis data, CLM findings,
or mechanical properties of the articular cartilage.
In this study, histologic evaluation of cartilage immediately after surgery (week 0)
failed to identify the chondrocyte injury detected by CLM. This finding is similar to that
of others who reported little or no change in articular cartilage immediately after the
application of RF energy.1,8,11

It is possible that the inability to detect significant

histological changes in the chondrocytes immediately after RF application is because
morphologic changes are not yet present, or that routine histological evaluation is limited
in its ability to assess chondrocyte function immediately after this injury occurs. Though
histological evaluation did not detect significant cartilage change the day of surgery,
CLM analysis confirmed that chondrocyte death occurred immediately after RF
treatment. This is consistent with the findings of other investigators who demonstrated
that the use of CLM, with a live/dead cell staining technique, is more sensitive to acute
chondrocyte

death

application.3,5,44

than

traditional

histopathology

following

thermal

energy
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In summary, both bRF and mRF, when applied remotely to the soft tissues in the
rabbit stifle joint, led to chondrocyte death, particularly in the superficial 25% of the
articular surface. The remaining chondrocytes within the articular cartilage appeared to
maintain the extracellular matrix which provided ample mechanical strength to the
cartilage throughout the 14 weeks of this investigation. In addition, similar chondrocyte
damage was noted between RF devices when used at tissue ablation settings. These
results suggest that RF energy, even when applied remotely to the soft tissues within the
joint during arthroscopic surgery, is detrimental to chondrocyte health, and its used
should be limited.
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CHAPTER III
SUMMARY, IMPLICATIONS, AND CONCLUSIONS
Human and veterinary orthopedic surgeons have made a shift to be more
minimally invasive over the past few decades. The arthroscopic use of radiofrequency
(RF) energy has minimized the need for arthrotomy with open surgical manipulation of
many conditions within the joint. Surgeons have been able to shrink exuberant joint
capsular tissue, treat various meniscal injuries, and smooth fibrillated cartilage with both
bipolar and monopolar RF. However, RF energy has been shown to damage collagen
molecules and fibroblasts in joint capsular tissue and cause chondrocyte death in articular
cartilage. Although joint capsular tissue has the ability to repair itself articular cartilage
does not. Numerous investigations have documented the changes following the direct
treatment of joint capsular tissue and articular cartilage with RF energy; however, to the
author’s knowledge, this is the first study to document the changes in the articular
cartilage following remote treatment of the soft tissues in the joint. This is the first
investigation to report the mechanical function of RF treated cartilage and the response of
RF treated cartilage to Cosequin® therapy.
This study was able to document immediate chondrocyte death in the superficial
region (outer 25%) of the articular cartilage following the remote application of both bRF
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and mRF energy at tissue ablative settings. Confocal laser microscopy, with a live/dead
cell staining technique, was able to verify this immediate chondrocyte death when
traditional histopathology revealed normal chondrocyte morphology. This is consistent
with the findings of other investigators. A recent investigation reported a progressive
loss of proteoglycan staining in the cartilage extracellular matrix for 24 weeks following
direct application of RF energy. The authors concluded that this loss would continue
until there was complete mechanical failure of the articular cartilage. The study reported
here was unable to document progressive loss of chondrocyte function or proteoglycan
staining in the treated articular cartilage for 14 weeks after remote application of RF
energy.

Safranin-O staining of the proteoglycans in the extracellular matrix,

glycosaminoglycan (GAG) synthesis by the articular chondrocytes, chondrocyte viability
(CLM), and mechanical function of the articular cartilage were not significantly different
between weeks 4 and 14 in this investigation. This documents that, even though the
superficial layer of chondrocytes were dead, the chondrocytes in the deeper layers were
able to maintain the extracellular matrix and mechanical function of the treated articular
cartilage.
Other investigations have documented that bRF energy leads to significantly
greater treatment temperatures and chondrocyte destruction than mRF energy. This study
was unable to find consistently significant differences between the two treatment devices.
This is most likely because both devices were set at tissue ablative settings, used
intermittently, and evaluated under continuous fluid flow in an attempt to create similar
treatment temperatures.
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Rabbits fed 2% Cosequin®, by body weight, were not found to have significant
improvement in chondrocyte viability, proteoglycan staining, or GAG synthesis over
rabbits fed a normal diet. This is most likely because of the severity of the damage
created to the chondrocytes given that Cosequin® has previously been shown to only
affect chondromodulation in live cells.
One drawback of this investigation is that we did not measure the fluid or tissue
temperatures created within the rabbit stifles during RF treatment. A recent investigation
documented fluid temperatures 1cm from the RF probe tip in an artificially created joint
that was able to hold 25mL of fluid. It has previously been shown that the temperature
created by RF energy exponentially decreases as the distance from the probe tip
increases. It has also been shown that fluid temperatures greater than 45ºC will bring
about chondrocyte death. Thus, because of the small size of the rabbit stifles, fluid
temperatures created during this investigation may have contributed to the chondrocyte
damage seen.
Additional investigation of fluid and articular cartilage temperatures created by
remote RF application is warranted. The rabbit joints used in this investigation would be
similar in size to human wrist, ankle, or phalangeal joints. Studies investigating larger
joints would help document the changes created in the articular cartilage during RF
treatment of joint capsular and meniscal tissue. Different sized RF probes tested at a
variety of settings and various distances would be necessary to document the optimum
treatment required to eliminate chondrocyte death during remote application of RF
energy. Finally, the length of this investigation may not have been long enough to
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document depletion of the extracellular matrix or mechanical function of the articular
cartilage. Therefore, a study of greater length is indicated.
In conclusion, remote application of both bRF and mRF energy in rabbit stifles at
tissue ablative settings, under continuous fluid flow, in an intermittent fashion causes
immediate damage to the superficial (outer 25%) chondrocytes of the articular cartilage.
This immediate damage was found to be non-progressive and the metabolic activity and
mechanical function of the articular cartilage in this study was maintained throughout the
entire 14 weeks. Cosequin® was unable to create significant differences in treated
articular cartilage function when compared to controls.

